![PDF) The Empirical Effect of Generic Competition on Brand-Name Molecules in the U.S. Pharmaceutical Market | Nicholas Debany - Academia.edu PDF) The Empirical Effect of Generic Competition on Brand-Name Molecules in the U.S. Pharmaceutical Market | Nicholas Debany - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/63371327/mini_magick20200520-2201-1sap9zz.png?1589973621)
PDF) The Empirical Effect of Generic Competition on Brand-Name Molecules in the U.S. Pharmaceutical Market | Nicholas Debany - Academia.edu
Patent Docs: The Effects of the Actavis Decision on Reverse Payment Settlement Agreements in ANDA cases -- Four Years After
Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs | PLOS ONE
![The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c0a0ab0e5e8edb12353cb641a0026a8c62eba86b/16-Table2-1.png)
The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar
![Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11151-018-9627-y/MediaObjects/11151_2018_9627_Fig3_HTML.gif)
Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink
Patent Docs: The Effects of the Actavis Decision on Reverse Payment Settlement Agreements in ANDA cases -- Four Years After
Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs | PLOS ONE
![PDF] The Effect of Generic Drug Competition on Generic Drug Prices During the Hatch-Waxman 180-Day Exclusivity Period | Semantic Scholar PDF] The Effect of Generic Drug Competition on Generic Drug Prices During the Hatch-Waxman 180-Day Exclusivity Period | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/86e69913e01a8f5a08924a3495d9f00a4aea328e/35-Figure1-1.png)
PDF] The Effect of Generic Drug Competition on Generic Drug Prices During the Hatch-Waxman 180-Day Exclusivity Period | Semantic Scholar
![Generic entry, price competition, and market segmentation in the prescription drug market - ScienceDirect Generic entry, price competition, and market segmentation in the prescription drug market - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167718707001026-gr2.jpg)
Generic entry, price competition, and market segmentation in the prescription drug market - ScienceDirect
![Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11151-018-9627-y/MediaObjects/11151_2018_9627_Fig2_HTML.gif)
Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink
![The effect of generic market entry on antibiotic prescriptions in the United States | Nature Communications The effect of generic market entry on antibiotic prescriptions in the United States | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-23049-4/MediaObjects/41467_2021_23049_Fig1_HTML.png)